Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1
Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1
Active, not recruiting · NCT05030441 · Registry updated 2026-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1 | Clonal Cytopenia of Undetermined Significance | Active, not recruiting | Phase 2 | 2026-08-12 | NCT05030441 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gateway for Cancer Research | 32 |
| Servier Hellas Pharmaceuticals Ltd. | 1 |
| Washington University School of Medicine | 475 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic - Case Comprehensive Cancer Center | Cleveland | United States | 1 |
| Washington University School of Medicine | St Louis | United States | 895 |